NCT04911166: Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy |
|
|
| Recruiting | 1 | 16 | US | Atezolizumab and Interleukin-12 Gene Therapy | The Methodist Hospital Research Institute, Genentech, Inc. | Non-small Cell Lung Cancer | 12/24 | 12/25 | | |